Empowering Veterinarians: Volition's Nu.Q Vet Test Unveiled
Revolutionizing Veterinary Diagnostics with Nu.Q Vet Cancer Test
At the forefront of veterinary diagnostics, Volition is excited to highlight the Nu.Q Vet Cancer Test, a groundbreaking tool aimed at enhancing animal health during pivotal conferences. This year, the 97th Annual Western Veterinary Conference (WVC) is the stage for Volition's latest advancements. Renowned veterinary professionals, Dr. Sue Ettinger, Dr. Brett Cordes, and Dr. Tom Butera, will be leading discussions around this innovative test.
Engagement at WVC for Veterinary Community
The WVC, one of the most significant gatherings in the veterinary field, is poised to attract around 20,000 attendees from across the nation. Volition will be actively participating by hosting a meet and greet at exhibition booth #2943. This event not only provides an opportunity to connect but also showcases the transformative capabilities of the Nu.Q Vet Cancer Test.
Experts Present at the Conference
Veterinary professionals like Dr. Sue Ettinger, affectionately known as Dr. Sue Cancer Vet, will share her insights on the importance of early cancer detection in pets. Additionally, presentation topics will cover the integration of the Nu.Q Vet Cancer Test into routine practice.
Detailed Presentation Schedule
Throughout the conference, Volition will host several informative presentations:
Presentation on Canine Cancer Journey
Date: March 3
Time: 2:00 PM - 2:50 PM
Speaker: Dr. Sue Ettinger
Location: Ballroom F, Level 2
Topic: "Detect, Treat, Monitor: Navigating the Canine Cancer Journey with Nu.Q Vet Cancer Test".
Utilization of the Nu.Q Vet Test
Date: March 4
Time: 10:30 AM - 11:00 AM
Speaker: Dr. Brett Cordes
Location: Western Frontier, Learning Hub
Topic: "Utilizing the Nu.Q Vet Cancer Test in Practice".
Focus on Early Detection
Date: March 5
Time: 12:10 PM - 1:00 PM
Speaker: Dr. Tom Butera
Location: Ballroom J, Level 2
Topic: "The Nu.Q Vet Cancer Test - Early Detection with Canine Cancer Screening".
About the Western Veterinary Conference
The WVC Annual Conference stands as a cornerstone event for veterinary professionals, providing countless educational opportunities. The Mandalay Bay Convention Center in Las Vegas will serve as the venue for discussions that drive the veterinary field forward.
About Volition
Volition is a pioneering multi-national epigenetics company committed to enhancing healthcare through innovative diagnostic solutions. By focusing on earlier disease detection and ongoing monitoring, Volition aims to improve outcomes for animals facing life-altering conditions.
Developing user-friendly, cost-effective blood tests, Volition enables veterinary professionals to diagnose and monitor various diseases, particularly cancers and conditions related to NETosis. This approach not only has the potential to prolong lives but also enhances quality of life for animal patients.
Research and Development Focus
The core of Volition's operations is centered in locations such as Belgium and London, with a robust innovation laboratory in the U.S. This versatile infrastructure supports its ongoing commitment to veterinary and human health advancements.
Frequently Asked Questions
What is the Nu.Q Vet Cancer Test?
The Nu.Q Vet Cancer Test is a blood test developed to aid in the early detection of common cancers in dogs, helping veterinarians provide timely care.
When will the WVC Conference take place?
The WVC Conference is scheduled for March 2-5, highlighting various educational presentations and workshops designed for veterinary professionals.
Who will be presenting at Volition's booth?
Leading veterinary experts, including Dr. Sue Ettinger, Dr. Brett Cordes, and Dr. Tom Butera, will provide insights on the Nu.Q Vet Cancer Test.
Why is early detection important in veterinary medicine?
Early detection of illnesses such as cancer significantly improves treatment outcomes and enhances the quality of life for affected pets.
How does Volition contribute to veterinary diagnostics?
Volition develops innovative blood tests that allow for efficient and accurate diagnosis, enabling veterinary professionals to monitor animal health closely.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.